Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer By Ogkologos - November 4, 2024 1819 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG S1011 study Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR New analysis estimates over 21 million UK adults will be obese... May 18, 2022 Children with Acute Lymphoblastic Leukemia Can Skip Radiation to the Brain November 25, 2019 Cancer in My Community: Expanding Access to Genetic Testing in Mexico September 1, 2020 Activity and Safety of Regorafenib Plus Nivolumab in First-Line Treatment for... February 22, 2024 Load more HOT NEWS 癌症治疗期间如何保证日常活动的安全和独立执行 Why we need to continue to advocate for global tobacco control Lung Cancer Trial of Osimertinib Draws Praise—and Some Criticism Fatiga relacionada con el cáncer: Lo que las personas con cáncer...
